Trials / Completed
CompletedNCT00372333
IDEA-033 Open Label Study
A Multiple-Dose, Open-Label Safety, Compliance, and Usage Evaluation Study of Epicutaneously Applied IDEA-033 in Joint / Musculoskeletal Pain or Soft Tissue Inflammation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 491 (actual)
- Sponsor
- IDEA AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main aim of the study is to evaluate safety, efficacy, compliance, and usage of epicutaneously applied IDEA-033 in joint / musculoskeletal pain or soft tissue inflammation.
Detailed description
Multi-centre, one arm, multiple dose, open-label, at home usage study. Adult volunteers experiencing joint pain, musculoskeletal pain, stiffness, or soft tissue inflammation will be screened for study participation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDEA-033 |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2007-12-01
- Completion
- 2008-04-01
- First posted
- 2006-09-06
- Last updated
- 2009-03-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00372333. Inclusion in this directory is not an endorsement.